BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Nonalcoholic fatty liver disease
1
Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis
11/24/2020 12:41:21 PM | Browse: 12 | Download: 29
2
PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
10/24/2020 2:27:20 AM | Browse: 26 | Download: 45
3
Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?
9/21/2020 4:02:08 PM | Browse: 26 | Download: 59
4
Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation
9/9/2020 11:11:52 AM | Browse: 38 | Download: 81
5
Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling
7/23/2020 5:00:01 AM | Browse: 86 | Download: 94
6
Management of nonalcoholic fatty liver disease in the Middle East
7/7/2020 2:50:53 PM | Browse: 112 | Download: 46
7
Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
6/19/2020 9:46:52 AM | Browse: 122 | Download: 136
8
Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
5/21/2020 12:02:13 PM | Browse: 140 | Download: 155
9
Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα
5/14/2020 3:43:04 AM | Browse: 179 | Download: 156
10
MANF ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism
3/14/2020 3:03:29 PM | Browse: 158 | Download: 132
11
Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis
12/31/2019 7:02:25 AM | Browse: 185 | Download: 277
12
LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
12/6/2019 8:06:37 AM | Browse: 193 | Download: 235
13
MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes
11/14/2019 9:43:48 AM | Browse: 295 | Download: 323
14
Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
9/30/2019 2:14:06 AM | Browse: 307 | Download: 344
15
Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways
9/12/2019 8:50:34 AM | Browse: 135 | Download: 258
16
Exhaled breath analysis in hepatology: State-of-the-art and perspectives
8/14/2019 1:31:33 PM | Browse: 185 | Download: 175
17
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 222 | Download: 143
18
Freeze-dried Si-Ni-San powder can ameliorate high-fat-diet-induced non-alcoholic fatty liver disease
6/28/2019 12:22:27 PM | Browse: 340 | Download: 367
19
Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis
4/26/2019 3:40:00 AM | Browse: 327 | Download: 333
20
Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients
4/13/2019 6:00:06 AM | Browse: 300 | Download: 446
21
Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents
3/28/2019 9:14:41 AM | Browse: 338 | Download: 457
22
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 318 | Download: 258
23
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 262 | Download: 176
24
Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model
12/7/2018 3:57:11 AM | Browse: 360 | Download: 283
25
Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?
11/27/2018 1:56:41 PM | Browse: 296 | Download: 230
26
Mutual interaction between oxidative stress and endoplasmic reticulum stress in the pathogenesis of diseases specifically focusing on non-alcoholic fatty liver disease
10/17/2018 8:55:58 AM | Browse: 309 | Download: 331
27
PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease
9/26/2018 9:00:43 AM | Browse: 413 | Download: 287
28
Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
8/27/2018 7:22:43 AM | Browse: 460 | Download: 327
29
Associations between nonalcoholic fatty liver disease and ischemic stroke
7/27/2018 4:31:20 PM | Browse: 334 | Download: 286
30
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”
7/19/2018 7:04:34 AM | Browse: 348 | Download: 332
31
Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis
6/15/2018 9:13:16 AM | Browse: 369 | Download: 362
32
Mediterranean diet and nonalcoholic fatty liver disease
5/18/2018 2:03:19 AM | Browse: 487 | Download: 355
33
Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
5/18/2018 2:03:19 AM | Browse: 456 | Download: 218
34
Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
5/11/2018 10:51:26 AM | Browse: 371 | Download: 208
35
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
4/19/2018 7:56:07 AM | Browse: 449 | Download: 309
36
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
4/11/2018 8:28:49 AM | Browse: 543 | Download: 324
37
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 503 | Download: 357
38
Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data
1/26/2018 8:09:36 AM | Browse: 536 | Download: 339
39
Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice
1/26/2018 2:31:05 AM | Browse: 456 | Download: 251
40
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12/20/2017 2:49:19 AM | Browse: 511 | Download: 352
41
Palmitate induces fat accumulation by activating C/EBPβ-mediated G0S2 expression in HepG2 cells
11/20/2017 4:03:35 AM | Browse: 537 | Download: 412
42
Nonalcoholic fatty liver disease: Evolving paradigms
9/26/2017 12:18:54 AM | Browse: 736 | Download: 508
43
New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase Ⅱ trial
8/28/2017 6:54:48 AM | Browse: 510 | Download: 347
44
Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
8/14/2017 1:56:00 AM | Browse: 404 | Download: 438
45
Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease
6/14/2017 9:25:57 AM | Browse: 515 | Download: 495
46
Nonalcoholic fatty liver disease: Diagnostic biomarkers
5/16/2017 6:56:36 AM | Browse: 608 | Download: 665
47
Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
4/20/2017 3:58:56 PM | Browse: 901 | Download: 1037
48
Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma
4/20/2017 3:58:56 PM | Browse: 532 | Download: 625
49
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
2/26/2017 6:20:00 PM | Browse: 724 | Download: 857
50
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
11/26/2016 6:56:00 PM | Browse: 614 | Download: 678
Write to the Help Desk
© 2004-2020 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345